Skip to Content

PRESENT DAY

Current studies in enrollment stage


VYF04 (Yellow Fever)- Phase III study, randomized, active-controlled, modified double-blind, and parallel-group to investigate the immunogenicity and safety of vYF compared to authorized YF vaccines in the pediatric population from 9 months to 5 years of age.

PSK00029- Phase 3 study, randomized, active-controlled, modified double-blind, parallel-group, with 4 study groups and with lot-to-lot uniformity to investigate the safety and immunogenicity of a 4-dose regimen of a 21-valent conjugate pneumococcal vaccine in healthy infants and young children

Current studies in follow-up stage


VAN00013- Phase II multi-stage study to investigate the immunogenicity and safety of formulations of the pentavalent meningococcal vaccine

PSK03- Phase 3 study to investigate the safety and immunogenicity of a 4-dose regimen of a 21-valent conjugate pneumococcal vaccine in healthy infants and young children

PSK05- Phase 3, randomized, active-controlled, modified double-blind, parallel-group study with 2 study groups to investigate the safety of a 4-dose regimen of a 21-valent conjugate pneumococcal vaccine in healthy infants and young children


Studies completed between 2024/25


Nor-212- Phase 2 Study of Vaccine in infants 5 months old for the prevention of Gastroenteritis caused by Norovirus.

2019nCov_503- Phase 2/3 Study of Vaccine for the prevention of Covid-19 in infants 6 months to 2 years and 2 to 6 years.

VAE00017- Phase 2 Study for the prevention of Respiratory Syncytial Virus in people over 60 years old.